A Single Center, Randomized, Double-blinded, Placebo-controlled, Open-label, Positive-controlled, Four-way Crossover Study to Assess the Effect of a Single Oral Dose NKTR-118 Administration on QTc Interval Compared to Placebo, Using AVELOX (Moxifloxacin) as a Positive Control, in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2016
At a glance
- Drugs Naloxegol (Primary)
- Indications Constipation
- Focus Adverse reactions
- Sponsors AstraZeneca
- 09 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Apr 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 28 Mar 2011 New trial record